创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

魏立新, 张伯礼. 含重金属传统药物安全性研究进展[J]. 药学进展, 2020, 44(10): 759-765.
引用本文: 魏立新, 张伯礼. 含重金属传统药物安全性研究进展[J]. 药学进展, 2020, 44(10): 759-765.
WEI Lixin, ZHANG Boli. Advances in the Research on Safety of Traditional Medicine Containing Heavy Metals[J]. Progress in Pharmaceutical Sciences, 2020, 44(10): 759-765.
Citation: WEI Lixin, ZHANG Boli. Advances in the Research on Safety of Traditional Medicine Containing Heavy Metals[J]. Progress in Pharmaceutical Sciences, 2020, 44(10): 759-765.

含重金属传统药物安全性研究进展

Advances in the Research on Safety of Traditional Medicine Containing Heavy Metals

  • 摘要: 含重金属传统药物在我国临床应用历史悠久。含重金属传统药物中“有害元素”包括铜、铅、汞、砷、镉等,它们对人体的肝、肾、脑等靶器官均有潜在毒性,其毒性不仅与其化合物形态、价态相关,而且还与其传统炮制解毒工艺及配伍解毒方法密切相关。含重金属传统药物安全性控制研究的技术难点,主要在于生物体内极微量及不同形态、价态重金属化合物检测方法的开发。现阶段,含重金属传统药物安全性控制存在的核心问题,主要是以食品标准代替药品标准、以元素总含量代替化合物含量、以外源污染成分代替治疗主体成分等的片面评价体系。含重金属传统药物安全性控制需深入研究的关键科学问题,应包括重金属化合物的体内代谢与毒性机制、疗效评价与风险评估、安全性评价与标准制定等,特别要加强对重金属体内价态及不同价态的药代动力学等基础研究。综述含重金属传统药物安全性的研究进展,以期为传统药物中重金属成分安全性控制提供研究思路。

     

    Abstract: Traditional medicines containing heavy metals have a long history of clinical application in China. The "harmful elements" in such medicines include copper, lead, mercury, arsenic, and cadmium, etc, with potential toxicities mainly on liver, kidney, and brain. These toxicities are related to their species and valence, and are also closely related to their preparation and compatibility detoxification methods. The technical difficulty in safety control research of heavy metal-containing traditional medicines lies in the development of detection methods for extremely small amounts and different forms of heavy metal compounds in organisms. The key problems in the present study of heavy metal-containing traditional medicines are the one-sided evaluation as replacing medicinal standards with food standards, replacing content of chemical species with total metal elements, and replacing the remedy part with exogenous heavy metal contamination. The key scientific issues should be deeply investigated for the safety control of heavy metal-containing traditional medicines including the in vivo metabolism and toxicity mechanisms of heavy metal compounds, curative effect and risk evaluation, safety assessment and standards formulation, etc. It is particularly necessary to strengthen the fundamental research on the valence state and the pharmacokinetics of heavy metals with different valence states. This paper reviews the research progress on the safety of heavy metalcontaining traditional medicines and aims to provide ideas for the safety control study of heavy metal components in traditional medicines.

     

/

返回文章
返回